When was BetaGlue Technologies founded?

BetaGlue Technologies was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is BetaGlue Technologies located?

BetaGlue Technologies is headquartered in Milano, Italy.

How many employees does BetaGlue Technologies have?

As of Aug 31, 2026, the latest employee count at BetaGlue Technologies is 23.

Is BetaGlue Technologies a funded company?

BetaGlue Technologies is a funded company, having raised a total of $18.9M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jul 20, 2022.

When was the latest funding round of BetaGlue Technologies?

BetaGlue Technologies' latest funding was a $***** Series A round on Jun 07, 2024, with participation from 3 investors.

Where does BetaGlue Technologies rank among its competitors?

BetaGlue Technologies ranks 1st amongst 16 active competitors, of which 5 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Panacea, which secured $5.8M in Jan, 2025.

Who are the top competitors of BetaGlue Technologies?

BetaGlue Technologies' top competitors include Viewraysystems, Panacea and Kallisio. Among them, Panacea secured the most recent funding round in January, 2025.

BetaGlue Technologies - 2026 Company Profile, Funding & Competitors

BetaGlue Technologies is a series A company based in Milano (Italy), founded in 2017. It operates as a Provider of a radiotherapy platform for the treatment of solid tumors. BetaGlue Technologies has raised $18.9M in funding from investors like LIFTT, Neva SGR and Kairos. The company has 16 active competitors, including 5 funded and 4 that have exited. Its top competitors include companies like Viewraysystems, Panacea and Kallisio.

Company Details

Provider of a radiotherapy platform for the treatment of solid tumors. The company is involved in developing a proprietary medical device platform, and a proprietary drug delivery system. The medical device platform is based on the combination of radioactive glue, β-emitting radiotherapy, and external beam radiation therapy which is administered to patients suffering from several types of cancers.

Website: betaglue.com
Email ID: *****@betaglue.com

Key Metrics

Founded Year

2017

Location

Milano, Italy

Stage

Series A

Total Funding

$18.9M in 2 rounds

Latest Funding Round

Series A, Jun 07, 2024, $*****

Investors

LIFTT & 9 more

Ranked

1^st among 16 active competitors

Employee Count

23 as on Aug 31, 2026

Similar Companies

Viewraysystems & 18 more

View BetaGlue Technologies' full profile

BetaGlue Technologies has raised a total funding of $18.9M over 2 rounds. Its first funding round was on Jul 20, 2022. Its latest funding round was a Series A round on Jun 07, 2024 for $*****. 3 investors participated in its latest round. BetaGlue Technologies has 10 institutional investors.

Here is the list of recent funding rounds of BetaGlue Technologies:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 07, 2024	4588272	Series A	5022991	9534632	9500434	3560247
Jul 20, 2022	5574467	Series A	5771771	9782835	Fin Posillipo & 5 more	Profectus Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of BetaGlue Technologies's funding rounds and investors

BetaGlue Technologies' employee count trend

BetaGlue Technologies has 23 employees as of Aug 26. Here is BetaGlue Technologies's employee count trend over the years:

Employee count trend for BetaGlue Technologies

Uncover BetaGlue Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BetaGlue Technologies include Viewraysystems, Panacea and Kallisio. Here is the list of Top 10 competitors of BetaGlue Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BetaGlue Technologies 2017, Milano (Italy), Series A	Provider of a radiotherapy platform for the treatment of solid tumors	$18.9M	EIC Fund, Panakes Partners & 8 others	54/100
2nd	Viewraysystems 2004, Lage (Germany), Public	Manufacturer of MRI-guided radiation therapy systems for cancer treatment	$177M	F-Prime Capital, Next47 & 12 others	51/100
3rd	Panacea 1999, Kolar (India), Series A	Developer of devices for radiotherapy	$15.4M	New Enterprise Associates, Claypond Capital ... & 13 others	49/100
4th	Kallisio 2022, Baltimore (United States), Unfunded	Developer of 3D printed oral stents for head and neck cancer patients	-	-	41/100
5th	EMulate Therapeutics 2002, Seattle (United States), Public	Developer of radiofrequency based devices for treatment of cancers	$23.2M	-	39/100
6th	RITA Medical Systems 1994, Fremont (United States), Acquired	Products for oncology therapy	-	Avista Capital Partners, Synergy Ventures	33/100
7th	Innoblative Designs 2013, Chicago (United States), Seed	Developer of electrosurgical devices for multiple surgical procedures	$3.26M	Village Capital, VentureWell	30/100
8th	Medsphere 2002, Shanghai (China), Series A	Developer of radiofrequency ablation and minimally invasive electrosurgical medical devices	-	TF Capital, JAFCO Asia & 1 others	29/100
9th	THERYQ 2022, Peynier (France), Unfunded	Developer of radiotherapy machines for cancer treatment	-	-	29/100
10th	Ehmet Health 2015, Plymouth (United States), Seed	Developer of radiotherapeutic devices for treating breast cancer	$150K	-	28/100